Senate passes bill allowing Medicaid coverage pathway for FDA‑approved obesity medications
Senate Bill 433 sets a framework for Medicaid coverage of FDA‑approved obesity medications when medically necessary while preserving departmental authority over coverage criteria and cost controls; sponsor said it is not an open‑ended benefit and the Senate passed the bill 31–0.
The full story
Senator Boudreau presented Senate Bill 433, described in the transcript as creating a framework to allow Medicaid coverage of medically necessary, FDA‑approved obesity medications while preserving the Louisiana Department of Health's authority to set coverage criteria, prior authorization rules and align the benefit with available funding and federal requirements.
Sign up to keep reading.
Your free newsletter brings you what your city council, county, and school board discussed and decided.
Keep reading for free
Create a free account to finish this story and see the video, transcript and key details.
Continue with GoogleContinue with emailAlready have an account? Log in